RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of DCPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Deciphera Pharmaceuticals Inc stock price up 3.62% on Thursday
(Updated on Mar 28, 2024)

Sell candidate since Mar 21, 2024 Gain 1.48% PDF

The Deciphera Pharmaceuticals Inc stock price gained 3.62% on the last trading day (Thursday, 28th Mar 2024), rising from $15.18 to $15.73. During the last trading day the stock fluctuated 6.03% from a day low at $15.25 to a day high of $16.17. The price has been going up and down for this period, and there has been a -1.13% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 476 thousand more shares were traded than the day before. In total, 764 thousand shares were bought and sold for approximately $12.02 million.

The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.28% during the next 3 months and, with a 90% probability hold a price between $15.59 and $19.03 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

DCPH Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 6.14%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Deciphera Pharmaceuticals Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $15.87. On a fall, the stock will find some support from the short-term average at $15.36. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Deciphera Pharmaceuticals Inc stock

Deciphera Pharmaceuticals Inc finds support from accumulated volume at $15.59 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.92 between high and low, or 6.03%. For the last week, the stock has had daily average volatility of 3.78%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (DCPH) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Deciphera Pharmaceuticals Inc to open at $15.72, and during the day (based on 14 day Average True Range), to move between $15.06 and $16.40, which gives a possible trading interval of +/-$0.670 (+/-4.26%) up or down from last closing price. If Deciphera Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 8.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.75 (0.13%) than the support at $15.59 (0.89%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Deciphera Pharmaceuticals Inc stock A Buy?

Deciphera Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.239 Sell Candidate Unchanged

Predicted Opening Price for Deciphera Pharmaceuticals Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$15.72 ( 0.0848%) $15.73

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for DCPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 16.64 5.76 %
R2 16.29 3.53 %
R1 16.07 2.15 %
Current price: 15.73
Support S1 15.37 -2.32 %
S2 15.15 -3.70 %
S3 14.80 -5.93 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.36 10.36 %
R2 16.93 7.63 %
R1 15.75 0.127 %
Current price 15.73
Support S1 15.59 -0.89%
S2 14.39 -8.52%
S3 13.89 -11.70%

FAQ

What is the symbol for Deciphera Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Deciphera Pharmaceuticals Inc is DCPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Deciphera Pharmaceuticals Inc Stock?
Deciphera Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Deciphera Pharmaceuticals Inc Stock?
Deciphera Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Deciphera Pharmaceuticals Inc Stock.

What's the current price of Deciphera Pharmaceuticals Inc Stock?
As of the end of day on the 2024-03-28, the price of an Deciphera Pharmaceuticals Inc (DCPH) share was $15.73.

What is the 52-week high and low for Deciphera Pharmaceuticals Inc Stock?
The 52-week high for Deciphera Pharmaceuticals Inc Stock is $17.73 and the 52-week low is $9.90.

What is the market capitalization of Deciphera Pharmaceuticals Inc Stock?
As of the 2024-03-28, the market capitalization of Deciphera Pharmaceuticals Inc is 1.271B.

When is the next earnings date for Deciphera Pharmaceuticals Inc?
The upcoming earnings date for Deciphera Pharmaceuticals Inc is May 01, 2024.
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT